Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 40Leukemia, Myeloid, Chronic-Phase 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia 5Blast Crisis 5Neoplasm Metastasis 3Melanoma 3Leukemia, Myeloid, Acute 3Gastrointestinal Stromal Tumors 3Synovitis, Pigmented Villonodular 2Recurrence 2Leukemia, Myeloid, Accelerated Phase 2Substance Withdrawal Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibromatoses 1Neurofibroma, Plexiform 1Neurofibroma 1Neoplasms 1Neoplasm, Residual 1Mucosal Lentiginous Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Glioma 1Giant Cell Tumor of Tendon Sheath 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Chordoma 1Carcinoma, Squamous Cell 1

Interventions

Practice Guidelines as Topic 8Standard of Care 7Specimen Handling 7Early Intervention, Educational 5pertuzumab 3Trastuzumab 3Methods 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Educational Status 3Biopsy 3trastuzumab biosimilar HLX02 2pembrolizumab 2Taxes 2Paclitaxel 2PF-05280014 2Ontruzant 2Ogivri 2Minoxidil 2Letrozole 2High-Energy Shock Waves 2Docetaxel 2Acupuncture Therapy 22C4 antibody 2regadenoson 1palbociclib 1nilotinib 1lorcaserin 1fisetin 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anatomic Stage I Breast Cancer AJCC v8 × nilotinib × Clear all
NCT04205903 2025-06-29

Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
11 enrolled 9 charts
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡